In 2024, significant progress has been made in lung cancer management, including advancements in targeted therapies and immunotherapy. Precision medicine plays a pivotal role, and molecular profiling helps guide treatment decisions for personalized patient care. Emerging research also focuses on novel biomarkers and combination therapies to address resistance mechanisms and enhance treatment efficacy. These developments underscore the evolving landscape of lung cancer management, emphasizing a multidisciplinary approach to optimize patient care. We bring you an exclusive discussion on recent updates in lung cancer management.
Join our renowned speaker, Dr. Peush Bajpai , on 16 th January 2025 , 11:00 AM IST onwards. Stay tuned! Suggested readings Small Cell Lung Cancer Systemic Therapy: ASCO Guidelines 2024 USFDA Approves Ensartinib for Non-small Cell Lung Cancer USFDA Approves…
